5Vishnevsky AS,Bokhman YaV,Loutfi G.Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients[J].Eur J Gynaecol Oncol,1993,14(2):150.
6Kitchener H,Swart AM,Qian Q,et al.Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial):a randomised study[J].Lancet,2009,373(9658):125.
7Wheeler DT,Bristow RE,Kurman RJ.Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins[J].Am J Surg Pathol,2007,31(7):988.
1Petereit DG, Complete surgical staging in endometrial cancer provides prognostic information only. Semin Radiat Onco 1, 2000, 10 : 8 - 14.
2Chee JJ, Ho TH, Tay EH, et al, Endometrioid adenocarcinoma of the uterus:surgicopathological correlations and role of pelvic lymphadenectomy. Ann Acad Med Singapore, 2003, 32:670 - 675,.
3Dubuc LJ. The future of retreoperitoneal lymph node dissection.J Gynecol Obstet Biol Reprod Paris, 2000, 29:276 - 278.
4Benedet J L, Bender H, Jones H, et al. FIOG staging classifications and clinical practice guidelines in the management of gynecologic cancers.International of Gynecology&Obstetrics, 2000, 70 : 209 - 262.
5Ben-Shachar, Kenneth M, Vitellas, et al. The role of MRI in the conservative management of endometrial cancer. Gynecologic Oncology, 2004, 93:233 - 237.
6Thigpen JT,Brady MF,Alvarez RD,et al.Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma:a dose-response study by the Gynecologic Oncology Group[J].J Clin Oncol,1999,17(6):1736-1744.
7Imai M,Jobo T,Sato R,et al.Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations[J].Eur J Gynaecol Oncol,2001,22(3):217-220.
8Kinster RW.Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium[J].Cancer,1959,12:1106-1122.
9Kauppila A,Gronroos M,Nieminen U.Clinical outcome in endometrial cancer[J].Obstet Gynecol,1982,60(4):473-480.
10Lewis GC,Slack NH,Mortel R,et al.Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer[J].Gynecol Oncol,1974,2(2-3):368-376.
7Siegel R, Naishadham D,J ernal A Cancer statistics, 2013. CA CancerJ Clin, 2013, 63: 11 - 30.
8Lee CM, Szabo A, Shrieve DC, et al. Frequency and effect of adjuvant radiation therapy among women with stage I en?dometrial adenocarcinoma.JAMA, 2006, 295: 389-397.
9Niwa K, Tagami K, Lian Z, et al. Outcome of fertility - pre?serving treatment in young women with endometrial carcino?mas. BJOG. 2005,112: 317-320.
10Mohan DS. Samuels MA, Selim MA, et al. Long - term out?comes of therapeutic pelvic lymphadenectomy for stage I endome?trial adenocarcinoma GynecolOncol, 1998, 70: 165 -171.
